DoW Alzheimer’s Transforming Care Award
Defense Health Agency Contracting Activity - DHACA
Free. Verify your email, then we send one reminder only.
- Posted
- May 1, 2026
- Amount
- Program total $5.4M
- Closes
- Sep 24, 2026 (in 9 days)
Similar opportunities open now
- DoW Alzheimer’s Transforming Diagnosis AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 9 days
- DoW Alzheimer’s Transforming Research AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 9 days
- DoW Duchenne Muscular Dystrophy, Clinical/Translational Research AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 3 days
- DoW Spinal Cord Injury, Clinical Translation Research AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 58 days
- DoW Traumatic Brain Injury and Psychological Health, Translational Research AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 30 days
Classification and identifiers
- Solicitation number
- HT942526AZRPTRCA
- Assistance listing (CFDA)
- 12.420
Amount
Program total $5.4M
Who can apply
About this opportunity
Summary: The fiscal year 2026 (FY26) Alzheimer’s Research Program (AZRP) Transforming Care Award (TrCA) supports clinical research or clinical trials evaluating interventions, innovations, and solutions in critical areas for dementia care for individuals with Alzheimer’s disease and Alzheimer’s disease related dementia (AD/ADRD) and their care partner(s). Distinctive Features: Clinical research and clinical trials are allowed; however, clinical trials solely testing or evaluating pharmacological interventions do not meet the intent of this funding opportunity. Studies utilizing animal models do not meet the intent of the mechanism and are not allowed. Preliminary data are required. Community collaboration is required for research prospectively enrolling human subjects. The AZRP encourages ...